We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




How Foods Fight Cancer

By Biotechdaily staff writers
Posted on 25 Jul 2005
"Compounds like sulforaphane in broccoli and resveratrol in wine have been shown to prevent cancer. More...
They do that by signaling our bodies to ramp up the production of proteins capable of preventing damage to our DNA. We now have a good idea how that signal works,” said Dr. Andrew Mesecar, associate professor of pharmaceutical biotechnology at the University of Illinois at Chicago (UIC) College of Pharmacy (USA), following a recent study.

Two major proteins, Keap1 and Nrf2, are involved in prompting the fight against cancer when disease-preventing foods are ingested, according to the UIC researchers. Keap1, the sensor protein, detects the presence of dietary substances such as sulforaphane when they bind with its cysteine residues, one of the amino acids that make up proteins. Keap1 attaches to Nrf2, the messenger that activates the genes for the protective proteins, avoiding DNA damage.

"Earlier studies in mice suggested that natural cancer-preventing compounds worked by severing the tie between Keap1 and Nrf2, freeing Nrf2 to take action,” Dr. Mesecar remarked. "But the signaling doesn't happen this way in humans.”

The researchers discovered that in humans the connection between the two proteins is not disrupted. What is significant, the investigators reported, is the alteration of cysteines in Keap1. They discovered that one specific cysteine was among the most likely to be modified in the interaction with cancer-preventing compounds.

This finding corresponded with results from other researchers. As a result, the scientists are proposing that the alteration of only this one amino acid in Keap1 is the critical step that triggers increases of the messenger Nrf2, and as a result, increased production of the protective proteins.

Keap1 is a potential new target for drugs to combat many different types of cancer, according to Dr. Mesecar. "One way of preventing cancer may be to eat certain foods rich in cancer-preventing compounds. An alternative is identifying how these compounds work and replicating their modes of action with drugs,” noted Dr. Mesecar.

The study was published in the June 12, 2005, online edition of the Proceedings of the [U.S.] National Academy of Sciences.




Related Links:
University of Illinois at Chicago

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.